Fulminant cytomegalovirus myocarditis in an immunocompetent host: Resolution with oral valganciclovir

Santosh K. Padala; Anupam Kumar; Sandeep Padala

doi:10.14503/THIJ-13-3504

Fulminant cytomegalovirus myocarditis in an immunocompetent host: Resolution with oral valganciclovir

Santosh K. Padala, Anupam Kumar, Sandeep Padala

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

We report a case of fulminant myocarditis after a primary cytomegalovirus infection, in a previously healthy 72-year-old woman. The infection underwent clinical and immunologic resolution consequent to treatment with oral valganciclovir. In an immunocompetent host, the primary cytomegalovirus infection is usually asymptomatic or manifests itself as a heterophile-negative mononucleosis-like syndrome. Cytomegalovirus myocarditis is uncommon in immunocompetent patients. After presenting our case, we review the literature on cytomegalovirus myocarditis in immunocompetent individuals.

Original language	English (US)
Pages (from-to)	523-529
Number of pages	7
Journal	Texas Heart Institute Journal
Volume	41
Issue number	5
DOIs	https://doi.org/10.14503/THIJ-13-3504
State	Published - Sep 1 2014
Externally published	Yes

Keywords

Antiviral agents/therapeutic use
Cytomegalovirus infections/ drug therapy
Immunocompetence
Myocarditis/etiology
Valganciclovir

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.14503/THIJ-13-3504

Cite this

@article{e91c95cd2d4f455ebb3ccb941bf25e91,

title = "Fulminant cytomegalovirus myocarditis in an immunocompetent host: Resolution with oral valganciclovir",

abstract = "We report a case of fulminant myocarditis after a primary cytomegalovirus infection, in a previously healthy 72-year-old woman. The infection underwent clinical and immunologic resolution consequent to treatment with oral valganciclovir. In an immunocompetent host, the primary cytomegalovirus infection is usually asymptomatic or manifests itself as a heterophile-negative mononucleosis-like syndrome. Cytomegalovirus myocarditis is uncommon in immunocompetent patients. After presenting our case, we review the literature on cytomegalovirus myocarditis in immunocompetent individuals.",

keywords = "Antiviral agents/therapeutic use, Cytomegalovirus infections/ drug therapy, Immunocompetence, Myocarditis/etiology, Valganciclovir",

author = "Padala, {Santosh K.} and Anupam Kumar and Sandeep Padala",

note = "Publisher Copyright: {\textcopyright} 2014 by the Texas Heart {\textregistered} Institute, Houston.",

year = "2014",

month = sep,

day = "1",

doi = "10.14503/THIJ-13-3504",

language = "English (US)",

volume = "41",

pages = "523--529",

journal = "Texas Heart Institute Journal",

issn = "0730-2347",

publisher = "Texas Heart Institute",

number = "5",

}

TY - JOUR

T1 - Fulminant cytomegalovirus myocarditis in an immunocompetent host

T2 - Resolution with oral valganciclovir

AU - Padala, Santosh K.

AU - Kumar, Anupam

AU - Padala, Sandeep

PY - 2014/9/1

Y1 - 2014/9/1

N2 - We report a case of fulminant myocarditis after a primary cytomegalovirus infection, in a previously healthy 72-year-old woman. The infection underwent clinical and immunologic resolution consequent to treatment with oral valganciclovir. In an immunocompetent host, the primary cytomegalovirus infection is usually asymptomatic or manifests itself as a heterophile-negative mononucleosis-like syndrome. Cytomegalovirus myocarditis is uncommon in immunocompetent patients. After presenting our case, we review the literature on cytomegalovirus myocarditis in immunocompetent individuals.

AB - We report a case of fulminant myocarditis after a primary cytomegalovirus infection, in a previously healthy 72-year-old woman. The infection underwent clinical and immunologic resolution consequent to treatment with oral valganciclovir. In an immunocompetent host, the primary cytomegalovirus infection is usually asymptomatic or manifests itself as a heterophile-negative mononucleosis-like syndrome. Cytomegalovirus myocarditis is uncommon in immunocompetent patients. After presenting our case, we review the literature on cytomegalovirus myocarditis in immunocompetent individuals.

KW - Antiviral agents/therapeutic use

KW - Cytomegalovirus infections/ drug therapy

KW - Immunocompetence

KW - Myocarditis/etiology

KW - Valganciclovir

UR - http://www.scopus.com/inward/record.url?scp=84908103149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908103149&partnerID=8YFLogxK

U2 - 10.14503/THIJ-13-3504

DO - 10.14503/THIJ-13-3504

M3 - Article

C2 - 25425988

AN - SCOPUS:84908103149

SN - 0730-2347

VL - 41

SP - 523

EP - 529

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

IS - 5

ER -

Fulminant cytomegalovirus myocarditis in an immunocompetent host: Resolution with oral valganciclovir

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this